ResMed Q1 Adj. EPS $2.91 Beats $2.67 Estimate, Sales $1.415B Beat $1.392B Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings Beats
ResMed (NYSE:RMD) reported quarterly earnings of $2.91 per share which beat the analyst consensus estimate of $2.67 by 8.99 percent. This is a 14.12 percent increase over earnings of $2.55 per share from the same period
ResMed (NYSE:RMD) reported quarterly earnings of $2.91 per share which beat the analyst consensus estimate of $2.67 by 8.99 percent. This is a 14.12 percent increase over earnings of $2.55 per share from the same period last year. The company reported quarterly sales of $1.415 billion which beat the analyst consensus estimate of $1.392 billion by 1.65 percent. This is a 5.91 percent increase over sales of $1.336 billion the same period last year.